Amedeo Smart

Free Medical Literature Service


 

Amedeo

Schizophrenia

  Free Subscription

Articles published in
Pharmacopsychiatry
    February 2024
  1. HART XM, Mitsukura Y, Bies RR, Uchida H, et al
    Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis.
    Pharmacopsychiatry. 2024 Feb 22. doi: 10.1055/a-2258-0379.
    >> Share

    January 2024
  2. BREIT S, Meyer A, Schmitt W, Bracht T, et al
    The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response.
    Pharmacopsychiatry. 2024;57:13-20.
    >> Share

    July 2023
  3. WAGNER E, Strube W, Gorlitz T, Aksar A, et al
    Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.
    Pharmacopsychiatry. 2023 Jul 28. doi: 10.1055/a-2110-4259.
    >> Share

    May 2023

  4. [Not Available].
    Pharmacopsychiatry. 2023;56:127.
    >> Share

    March 2023
  5. SPOOV J
    The Mini-TRH Test.
    Pharmacopsychiatry. 2023;56:51-56.
    >> Share

  6. BARTSCH JC, Schott BH, Behr J
    Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review.
    Pharmacopsychiatry. 2023;56:57-63.
    >> Share

    November 2022
  7. AGUGLIA A, Fusar-Poli L, Natale A, Amerio A, et al
    Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study.
    Pharmacopsychiatry. 2022;55:281-289.
    >> Share

    July 2022
  8. COLIJN MA
    The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms.
    Pharmacopsychiatry. 2022 Jul 11. doi: 10.1055/a-1882-6802.
    >> Share

  9. KISHI T, Sakuma K, Iwata N
    Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis.
    Pharmacopsychiatry. 2022 Jul 5. doi: 10.1055/a-1860-2793.
    >> Share

  10. LOPEZ-MORINIGO JD, Leucht S, Arango C
    Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
    Pharmacopsychiatry. 2022 Jul 1. doi: 10.1055/a-1854-0185.
    >> Share

    June 2022
  11. ESEN-SEHIR D, Kopf J, Hagele S, Plichta MM, et al
    Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Pharmacopsychiatry. 2022 Jun 22. doi: 10.1055/a-1811-7241.
    >> Share

    May 2022
  12. MIURA G, Tanaka K, Kemuriyama T, Misawa F, et al
    Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2022 May 5. doi: 10.1055/a-1811-7318.
    >> Share

    January 2022
  13. VEERMAN SRT, Bogers JPAM, Cohen D, Schulte PFJ, et al
    COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
    Pharmacopsychiatry. 2022;55:48-56.
    >> Share

    May 2021
  14. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016